Lundbeck
HLUN-B.CO
#2865
Rank
โ‚น369.09 B
Marketcap
โ‚น383.80
Share price
7.19%
Change (1 day)
-2.16%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): โ‚น46.48 Billion

According to Lundbeck 's latest financial reports the company's current earnings are โ‚น3.18 Billion. , an increase over its 2023 earnings that were of โ‚น37.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น47.37 B25.46%
2023 โ‚น37.76 B21.69%
2022 โ‚น31.03 B31.79%
2021 โ‚น23.54 B-4.53%
2020 โ‚น24.66 B-45.08%
2019 โ‚น44.90 B-33.97%
2018 โ‚น68.00 B12.76%
2017 โ‚น60.31 B94.32%
2016 โ‚น31.03 B-136.98%
2015 -โ‚น83.94 Billion-1258.1%
2014 โ‚น7.24 B-72.43%
2013 โ‚น26.28 B4.31%
2012 โ‚น25.19 B-55.26%
2011 โ‚น56.33 B6.64%
2010 โ‚น52.82 B-6.68%
2009 โ‚น56.60 B